http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1284731-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae84948901b77f34fd51c41264d8d19c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428
filingDate 2001-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec031dbce81702fca7ea2e8c5d4523d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_046f37e5728b506f27dfd9f7a4fb8203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3a4a8c06b0135392be6f6cb0075a0e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37ef58fc92fe3c7579b45bca87f63d45
publicationDate 2003-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1284731-A1
titleOfInvention Use of compounds having combined dopamine d2, 5-ht1a and alpha adrenoreceptor agonistic action for treating cns disorders
abstract The invention relates to the use of compounds having combined sopamine D2 agonistic activity, 5-HT1A agonistic activity and a adrenoceptor agonistic activity for the treatment of CNS disorders such as Parkinson's disease.
priorityDate 2000-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7970
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID38020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226899842
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127860575
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12068247
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7963
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22857281
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18598488
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128218919
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226433954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544741
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226433871
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID38020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127402247
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7975
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6420096
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128955923
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518507
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127561449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7498
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226899841
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5170076
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426061070
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574860
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2783370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129951575

Total number of triples: 65.